Signs and Symptoms
Clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient.
Subtype terms (39)
More specific conditions that are subtypes of Signs and Symptoms in the MeSH hierarchy.
- Aging, Premature
3 drugs (2 approved, 1 experimental)
- Asthenia
5 drugs (1 approved, 4 experimental)
- Body Odor
- Body Temperature Changes
8 drugs (6 approved, 2 experimental)
- Body Weight
102 drugs (44 approved, 58 experimental)
- Cardiac Output, High
3 drugs approved
- Cardiac Output, Low
19 drugs (12 approved, 7 experimental)
- Chills
3 drugs approved
- Cyanosis
2 drugs (1 approved, 1 experimental)
- Edema
94 drugs (63 approved, 31 experimental)
- Eye Manifestations
2 drugs approved
- Failure to Thrive
2 drugs approved
- Fatigue
163 drugs (88 approved, 75 experimental)
- Feminization
- Fetal Distress
7 drugs (5 approved, 2 experimental)
- Heart Murmurs
- Hot Flashes
79 drugs (45 approved, 34 experimental)
- Hypergammaglobulinemia
- Hyperlactatemia
11 drugs approved
- Hypertriglyceridemic Waist
1 drug approved
- Intermittent Claudication
59 drugs (27 approved, 32 experimental)
- Medically Unexplained Symptoms
1 drug approved
- Mobility Limitation
18 drugs (11 approved, 7 experimental)
- Motion Sickness
14 drugs (10 approved, 4 experimental)
- Myocardial Stunning
12 drugs (9 approved, 3 experimental)
- Neurologic Manifestations
18 drugs (14 approved, 4 experimental)
- Oral Manifestations
8 drugs (5 approved, 3 experimental)
- Polydipsia
- Prodromal Symptoms
1 drug approved
- Pseudophakia
7 drugs approved
- Renal Colic
42 drugs (32 approved, 10 experimental)
- Reticulocytosis
- Signs and Symptoms, Digestive
15 drugs (6 approved, 9 experimental)
- Signs and Symptoms, Respiratory
9 drugs (8 approved, 1 experimental)
- Skin Manifestations
15 drugs (10 approved, 5 experimental)
- Sleepiness
5 drugs (3 approved, 2 experimental)
- Travel-Related Illness
1 drug experimental
- Urological Manifestations
51 drugs (30 approved, 21 experimental)
- Virilism
Drugs by status
Phase 4 trials (18)
Phase 2 trials (10)
Phase 1 trials (7)
Organizations
Organization Involved with Phase 4 Indications (24)
- AstraZeneca
- Merck
- Pfizer
- Novartis
- FinnMedi Oy
- Mallinckrodt
- Ursapharm Arzneimittel GmbH
- Boehringer Ingelheim
- Lifelong Vision Foundation
- Danderyds Hospital
- McMaster University
- Ophthalmic Consultants of Long Island
- University of Tampere
- University of Toronto
- University of Zagreb
- University of California, Los Angeles
- National Taiwan University
- Toyos Clinic
- Kharkov District Clinical Hospital
- Innovative Medical Research of South Florida, Inc
- University of Western Ontario
- Government of Finland
- University of Helsinki
- Pepose Vision Institute
Organization Involved with Phase 3 Indications (19)
- Actavis
- Roche
- Sandoz
- Recordati
- Eli Lilly
- ICOS
- Santen Inc.
- Catalysis SL
- Corcept Therapeutics
- Novaliq GmbH
- Hoosier Cancer Research Network
- Sheffield Hallam University
- Azidus
- Amneal Pharmaceuticals
- Moscow State University
- Novum Pharmaceutical Research Services
- Watson Pharmaceuticals
- Heroes del Moncada Polyclinic
- Oyster Point Pharma, Inc.
Organization Involved with Phase 2 Indications (18)
- Astellas
- Biopolis S.L.
- Leti Pharma GmbH
- ORA, Inc.
- PediaMed Pharmaceuticals
- Resolvyx Pharmaceuticals, Inc
- Transition Therapeutics
- Cheng Hsin Rehabilitation Medical Center
- Faculdade de Medicina do ABC
- Gillette Children's Specialty Healthcare
- Hospital Universitario Central de Asturias
- University of Bristol
- University of Strasbourg
- University of Mannheim
- Total Eye Care, PA
- Central Maine Eye Care
- The Eye Care Group, Waterbury, CT
- Government of Spain
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (19)
- Gilead Sciences
- Nutrition 21, Inc.
- Tissue Tech Inc.
- VSL Pharmaceuticals
- National Cancer Institute (NCI)
- Rockefeller University
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Jordan Collaborating Cardiology Group
- Minia University
- University of Copenhagen
- Trinity College Dublin
- Broward Research Group
- University of Ljubljana
- Embria Health Sciences
- Cargill
- Nestle
- PharmaLinea d.o.o.
- Diagnostic Laboratory Medicare PLUS d.o.o.
- Clinres Farmacija d.o.o.